231 related articles for article (PubMed ID: 20368408)
1. Sitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4+ T-cell migration through incretin-dependent and -independent pathways.
Kim SJ; Nian C; McIntosh CH
Diabetes; 2010 Jul; 59(7):1739-50. PubMed ID: 20368408
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation.
Kim SJ; Nian C; Doudet DJ; McIntosh CH
Diabetes; 2009 Mar; 58(3):641-51. PubMed ID: 19073764
[TBL] [Abstract][Full Text] [Related]
3. The effects of DPP-IV inhibition in NOD mice with overt diabetes.
Vargová L; Zacharovová K; Dovolilová E; Vojtová L; Cimburek Z; Saudek F
Folia Biol (Praha); 2013; 59(3):116-22. PubMed ID: 23890479
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.
Kim SJ; Nian C; Doudet DJ; McIntosh CH
Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314
[TBL] [Abstract][Full Text] [Related]
5. Effects of dipeptidyl peptidase IV inhibitor sitagliptin on immunological parameters of lymphocytes in intact animals and animals with experimental autoimmune process.
Robinson MV; Mel'nikova EV; Trufakin VA
Bull Exp Biol Med; 2014 Nov; 158(1):66-9. PubMed ID: 25408522
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A/VEGFR-2 signaling pathway.
Samikannu B; Chen C; Lingwal N; Padmasekar M; Engel FB; Linn T
PLoS One; 2013; 8(12):e82639. PubMed ID: 24349326
[TBL] [Abstract][Full Text] [Related]
7. The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose.
Bock G; Dalla Man C; Micheletto F; Basu R; Giesler PD; Laugen J; Deacon CF; Holst JJ; Toffolo G; Cobelli C; Rizza RA; Vella A
Clin Endocrinol (Oxf); 2010 Aug; 73(2):189-96. PubMed ID: 20039889
[TBL] [Abstract][Full Text] [Related]
8. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.
Waget A; Cabou C; Masseboeuf M; Cattan P; Armanet M; Karaca M; Castel J; Garret C; Payros G; Maida A; Sulpice T; Holst JJ; Drucker DJ; Magnan C; Burcelin R
Endocrinology; 2011 Aug; 152(8):3018-29. PubMed ID: 21673098
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase IV inhibition does not adversely affect immune or virological status in HIV infected men and women: a pilot safety study.
Goodwin SR; Reeds DN; Royal M; Struthers H; Laciny E; Yarasheski KE
J Clin Endocrinol Metab; 2013 Feb; 98(2):743-51. PubMed ID: 23264399
[TBL] [Abstract][Full Text] [Related]
10. Long-term inhibition of dipeptidyl-peptidase 4 reduces islet infiltration and downregulates IL-1β and IL-12 in NOD mice.
He X; Li W; Xie Y; Zhao Y
Int Immunopharmacol; 2020 Nov; 88():106945. PubMed ID: 33182020
[TBL] [Abstract][Full Text] [Related]
11. Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study.
Price JD; Linder G; Li WP; Zimmermann B; Rother KI; Malek R; Alattar M; Tarbell KV
Clin Exp Immunol; 2013 Oct; 174(1):120-8. PubMed ID: 23711188
[TBL] [Abstract][Full Text] [Related]
12. Sitagliptin exerts an antinflammatory action.
Makdissi A; Ghanim H; Vora M; Green K; Abuaysheh S; Chaudhuri A; Dhindsa S; Dandona P
J Clin Endocrinol Metab; 2012 Sep; 97(9):3333-41. PubMed ID: 22745245
[TBL] [Abstract][Full Text] [Related]
13. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
Jackson EK; Mi Z; Tofovic SP; Gillespie DG
Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
[TBL] [Abstract][Full Text] [Related]
14. Significance of vascular dipeptidyl peptidase-4 inhibition on vascular protection in Zucker diabetic fatty rats.
Takai S; Sakonjo H; Jin D
J Pharmacol Sci; 2014; 125(4):386-93. PubMed ID: 25030743
[TBL] [Abstract][Full Text] [Related]
15. Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors.
Zettl H; Schubert-Zsilavecz M; Steinhilber D
ChemMedChem; 2010 Feb; 5(2):179-85. PubMed ID: 20029928
[No Abstract] [Full Text] [Related]
16. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
17. Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
Alonso N; Julián MT; Carrascal J; Colobran R; Pujol-Autonell I; Rodriguez-Fernández S; Teniente A; Fernández MA; Miñarro A; Ruiz de Villa MC; Vives-Pi M; Puig-Domingo M
PLoS One; 2015; 10(11):e0142186. PubMed ID: 26555789
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase IV inhibitor improves the salivary gland histology of spontaneously diabetic mice.
da Silva Faria AL; Dias MA; Leme VB; Mayoral EE; da Silva RE; Mâncio RD; Ferreira Junior RS; Caldeira EJ
Arch Oral Biol; 2013 Jul; 58(7):755-61. PubMed ID: 23107049
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased β cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetes.
Shirakawa J; Amo K; Ohminami H; Orime K; Togashi Y; Ito Y; Tajima K; Koganei M; Sasaki H; Takeda E; Terauchi Y
J Biol Chem; 2011 Jul; 286(29):25467-76. PubMed ID: 21613229
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
Jackson EK; Kochanek SJ; Gillespie DG
Hypertension; 2012 Sep; 60(3):757-64. PubMed ID: 22802229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
